Senseonics (SENS) - Kapitalizatsiyaning foydaga nisbati

Eversense (SENS) korporativ emblemasi va logotipi

Senseonics Holdings (SENS) bozor dinamikasi -4.70 metrik qiymatini ko'rsatmoqda. Biznes jiddiy foyda tanqisligi va tashqi moliyalashtirishga bog'liqlik bilan tavsiflanuvchi xavfli moliyaviy modelga tayanadi. O'sish ixtisoslashtirilgan markazlar bilan hamkorlik, IT integratsiyalar va dasturiy ta'minot litsenziyalarini sotib olish hisobiga amalga oshirilmoqda. Asosiy katalizator sifatida sug'urta qamrovining kengayishini kutayotgan yillik glyukoza monitoringi sensorining bozorga chiqarilishi namoyon bo'lmoqda.

Senseonics (SENS): Narx-foyda koeffitsiyenti 04.07.2022dan 16.11.2026gacha

Senseonics Holdings, Inc. (SENS) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

Kompaniyaning umumiy tahlili:Senseonics Corp - SENS
Senseonics ishlab chiqargan mahsulot

P/E koeffitsiyenti bir dollar foydaning tannarxini aks ettirib, biznesning o'sish sur'atlariga oid bozor kutganlarini baholash imkonini beradi. Senseonics Holdings (SENS) uchun ushbu hisob-kitob juda muhimdir, chunki Eversense sensorlariga bo'lgan elastik talab narxlarni belgilash imkoniyatini cheklaydi. Senseonics Holdings (SENS) ning konsolidatsiyalashgan P/E koeffitsiyentini tahlil qilish orqali investor bozor shoklaridan keyin kapitalizatsiyaning tiklanish tezligini aniqlashi mumkin. Ushbu koeffitsiyentning tendentsiyasi implantlarning noyob operatsion foydalanish muddati tufayli modelning fundamental barqarorligini tasdiqlaydi.

Raqobatdosh kompaniyalar tahlili

Dexcom - Kapitalizatsiyaning sof foydaga nisbati|Narx-foyda koeffitsiyenti PEN (Penumbra Inc)|NOVT - Kapitalizatsiyaning foydaga nisbati|Haemonetics Corp. - Narx-foyda koeffitsiyenti|P/E multiplikatori Inspire Medical Systems, Inc. INSP|PRCT: Narx-foyda koeffitsiyenti|CONMED - Bozor narxining sof foydaga nisbati|PLSE: P/E multiplikatori|INMD - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti PMI|Narx-foyda koeffitsiyenti Surmodics (SRDX)|Narx-foyda koeffitsiyenti NPCE (NeuroPace)|TCMD (Tactile Systems Technology, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati SANUWAVE Health Inc SNWV|OM: Narx-foyda multiplikatori|Electromed Inc - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati LENSAR, Inc.|RCEL: P/E multiplikatori|Narx-foyda multiplikatori PROF|BDMD (Baird Medical) - P/E multiplikatori|EDAP TMS S.A. (EDAP) - Biznesning o‘zini qoplash muddati|P/E multiplikatori APYX|Narx-foyda koeffitsiyenti IceCure Medical ICCM|P/E multiplikatori LUNG (Pulmonx Corp)|P/E multiplikatori TELA Bio, Inc. TELA|CTSO - Narxning foydaga nisbati|SRTS: Narxning foydaga nisbati|ZYXI (Zynex, Inc.) - Narx-foyda koeffitsiyenti|electroCore Inc - Kompaniya qiymatining sof foydaga nisbati|RBOT (Vicarious Surgical Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati inspira-technologies.com IINN|Narx-foyda koeffitsiyenti ICU (SeaStar Medical Holding Corporation)|IRIDEX Corp. (IRIX) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Intelligent Bio Solutions Inc - Narx-foyda koeffitsiyenti|P/E multiplikatori AINostix XAIR|Profusa Inc. - P/E multiplikatori|Biznesning o‘zini qoplash muddati STRATA Skin Sciences, Inc. SSKN|GlucoTrack (GCTK) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati NAOV (NanoVibronix Inc.)|Narxning foydaga nisbati venusconcept.com|Narx-foyda koeffitsiyenti Nuwellis, Inc. (NUWE)|P/E multiplikatori AEMD|ASXC - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Avinger, Inc. AVGR|BSGM: Narx-foyda multiplikatori|CUTR: Narx-foyda koeffitsiyenti|KNW - P/E multiplikatori|NARI: P/E multiplikatori|Narx-foyda multiplikatori NVRO|RSLS (ReShape Lifesciences, Inc.) - P/E multiplikatori|Silk Road Medical Inc (SILK) - Biznesning o‘zini qoplash muddati